On this episode of Standpoint, Gabe speaks with Annette Bakker, CEO of the Children's Tumor Foundation, and NF ambassador McKinnon Galloway about how a 57% cut to the CDMRP is threatening critical neurofibromatosis research. We discuss the real-world impact of these funding cuts on life-saving studies and technologies, including those that help patients like McKinnon, who relies on transcription due to her NF-related deafness.
